Search Results - "Malfertheiner, Maximillian V"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Effect of ex vivo extracorporeal membrane oxygenation flow dynamics on immune response by Ki, Katrina K, Passmore, Margaret R, Chan, Chris Hoi Houng, Malfertheiner, Maximillian V, Bouquet, Mahe, Cho, Hwa Jin, Suen, Jacky Y, Fraser, John F

    Published in Perfusion (01-04-2019)
    “…Background: Extracorporeal membrane oxygenation is a life-saving support for heart and/or lung failure patients. Despite technological advancement, abnormal…”
    Get full text
    Journal Article
  2. 2

    Mesenchymal stem cells may ameliorate inflammation in an ex vivo model of extracorporeal membrane oxygenation by von Bahr, Viktor, Millar, Jonathan E, Malfertheiner, Maximillian V, Ki, Katrina K, Passmore, Margaret R, Bartnikowski, Nicole, Redd, Meredith A, Cavaye, Michael, Suen, Jacky Y, McAuley, Danny F, Fraser, John F

    Published in Perfusion (01-04-2019)
    “…Introduction: Mesenchymal stem cells exhibit immunomodulatory properties which are currently being investigated as a novel treatment option for Acute…”
    Get full text
    Journal Article Conference Proceeding
  3. 3

    Administration of mesenchymal stem cells during ECMO results in a rapid decline in oxygenator performance by Millar, Jonathan Edward, von Bahr, Viktor, Malfertheiner, Maximillian V, Ki, Katrina K, Redd, Meredith A, Bartnikowski, Nicole, Suen, Jacky Y, McAuley, Danny Francis, Fraser, John F

    Published in Thorax (01-02-2019)
    “…Mesenchymal stem cells (MSCs) have attracted attention as a potential therapy for Acute Respiratory Distress Syndrome (ARDS). At the same time, the use of…”
    Get more information
    Journal Article
  4. 4
  5. 5
  6. 6

    Inhibition of proliferation of small intestinal and bronchopulmonary neuroendocrine cell lines by using peptide analogs targeting receptors by Kidd, Mark, Schally, Andrew V., Pfragner, Roswitha, Malfertheiner, Maximillian V., Modlin, Irvin M.

    Published in Cancer (15-03-2008)
    “…BACKGROUND. Currently, no consistently effective therapy is available to inhibit cell proliferation or metastasis of neuroendocrine tumor (NET) disease. The…”
    Get full text
    Journal Article
  7. 7